Detailed TOC of Global Next Generation Sequencing (NGS) Market Research Report 2025
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2019 VS 2025 VS 2033
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Growth by Application: 2019 VS 2025 VS 2033
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2019-2033)
2.2 Next Generation Sequencing (NGS) Growth Trends by Region
2.2.1 Global Next Generation Sequencing (NGS) Market Size by Region: 2019 VS 2025 VS 2033
2.2.2 Next Generation Sequencing (NGS) Historic Market Size by Region (2019-2025)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Region (2025-2033)
2.3 Next Generation Sequencing (NGS) Market Dynamics
2.3.1 Next Generation Sequencing (NGS) Industry Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2019-2025)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2019-2025)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2025
3.5 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2019-2025)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2025-2033)
5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2019-2025)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2025-2033)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2019-2033)
6.2 North America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2025 VS 2033
6.3 North America Next Generation Sequencing (NGS) Market Size by Country (2019-2025)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country (2025-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2019-2033)
7.2 Europe Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2025 VS 2033
7.3 Europe Next Generation Sequencing (NGS) Market Size by Country (2019-2025)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country (2025-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size (2019-2033)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Market Growth Rate by Region: 2019 VS 2025 VS 2033
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2019-2025)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2025-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Market Size (2019-2033)
9.2 Latin America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2025 VS 2033
9.3 Latin America Next Generation Sequencing (NGS) Market Size by Country (2019-2025)
9.4 Latin America Next Generation Sequencing (NGS) Market Size by Country (2025-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size (2019-2033)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2025 VS 2033
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2019-2025)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2025-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Detail
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.3.5 Pacific Biosciences of California Recent Development
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Detail
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.4.5 Beijing Genomics Institute Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.6.5 Roche Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.7.5 Agilent Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Detail
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.8.5 Perkinelmer Recent Development
11.9 Genomatix
11.9.1 Genomatix Company Detail
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.9.5 Genomatix Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Detail
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.10.5 PierianDx Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Detail
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.11.5 Eurofins Scientific Recent Development
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Detail
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.12.5 Gatc Biotech Recent Development
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Detail
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.13.5 Oxford Nanopore Technologies Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Detail
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Detail
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.15.5 DNASTAR Recent Development
11.16 Biomatters
11.16.1 Biomatters Company Detail
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.16.5 Biomatters Recent Development
11.17 Partek
11.17.1 Partek Company Detail
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.17.5 Partek Recent Development
11.18 New England Biolabs
11.18.1 New England Biolabs Company Detail
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.18.5 New England Biolabs Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
11.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.19.5 Myriad Genetics Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Detail
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2019-2025)
11.20.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
